Vaccine for Recurrent Urinary Tract Infections in Women

Completed · Phase 2

Conditions studied: Recurrent Urinary Tract Infections in Women

In brief

The purpose of this study is determine whether a vaginal mucosal vaccine given to women with a history of recurrent urinary tract infections can reduce the number of infections occurring in a six-month study period, as compared to placebo treatment.

Key facts

Study ID

NCT00261248

Run by

University of Wisconsin, Madison

People needed

75

Starts

1996-11-01

Expected to finish

2003-12-01

Last updated by the study team

2015-10-05

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Three or more urinary tract infections in the previous year

You may not qualify if…

• Neurogenic bladder
• Interstitial cystitis
• Urinary diversion
• Kidney stones
• Indwelling catheter

Where it is running

• University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.